\-\ Texto\\:\\ \ \(0\)\
\-\ large\\,\\ palpable\\,\\ tender\\ mass\\ in\\ r\\ neck\\,\\ posterior\\ to\\ the\\ mandible\\.\ \(0\)\
\-\ recommended\\ followup\\ includes\\ placement\\ of\\ ppd\\,\\ check\\ hiv\\ status\\,\\ and\\ fna\\ of\\ the\\ mass\\ if\\ any\\ clinical\\ suspicion\\ of\\ neoplastic\\ process\\.\\ \\ \ \(0\)\
\-\ standard\\ poly\\-pharmacy\\ treatment\\ for\\ m\\.\\ tuberculum\\ infection\\ is\\ usually\\ therapeutic\\.\ \(0\)\
\-\ large\\ heterogeneous\\ mass\\ posterior\\ to\\ r\\ mandible\\,\\ displacing\\ adjacent\\ structures\\.\ \(0\)\
\-\ multiple\\ necrotic\\ appearing\\ nodes\\ in\\ anterior\\ cervical\\ chains\ \(0\)\
\-\ scrofula\\ \\-\\ infectious\\ cervical\\ lymphadenitis\ \(0\)\
\-\ infection\\/abcess\ \(0\)\
\-\ \\ \\ tb\ \(1\)\
\-\ \\ \\ atypical\\ mycobacterium\\ \\(usually\\ not\\ painful\\)\ \(0\)\
\-\ \\ \\ staph\\/strep\\ \\(would\\ expect\\ these\\ with\\ sicker\\,\\ febrile\\ presentation\\)\ \(0\)\
\-\ \\ \\ if\\ immune\\ status\\ is\\ in\\ question\\,\\ the\\ infectious\\ differential\\ expands\\ to\\ include\\ many\\ others\\ especially\\ fungal\\.\ \(0\)\
\-\ lympho\\-proliferative\ \(0\)\
\-\ \\ \\ lymphoma\ \(3\)\
\-\ \\ \\ sarcoid\ \(0\)\
\-\ \\ \\ zebras\\ including\\ castleman\\'s\\ and\\ kimura\\'s\\ diseases\\.\ \(0\)\
\-\ malignancy\\ \\-\\-\\ location\\ is\\ good\\ for\\ primary\\ parotid\\ tumor\\ or\\ oro\\-pharyngeal\\ mets\\.\ \(0\)\
\-\ benign\\ neoplasm\\ \\(lipoma\\/neuroma\\/hemangioma\\)\ \(0\)\
\-\ congenital\\ \\(branchial\\ cleft\\ cysts\\)\ \(0\)\
\-\ trauma\\/vascular\\ \\(no\\ history\\)\\ pseudo\\-aneurysm\\ or\\ a\\-v\\ fistula\\.\ \(0\)\
\-\ 30\\ y\\/o\\ woman\\ with\\ 2\\ week\\ history\\ of\\ painful\\ neck\\ mass\\.\ \(1\)\
\-\ afebrile\\,\\ and\\ generally\\ well\\ appearing\\.\ \(0\)\
\-\ reports\\ h\\/o\\ mycobacterial\\ infection\\ in\\ past\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mandible\\:\\ 0\\.05464127900835606\ \(0\)\
\-\ poly\\-pharmacy\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ infection\\/abcess\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ staph\\/strep\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ sicker\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ lympho\\-proliferative\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ zebras\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ oro\\-pharyngeal\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ lipoma\\/neuroma\\/hemangioma\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ trauma\\/vascular\\:\\ 0\\.047651450940359455\ \(0\)\
\-\ painful\\:\\ 0\\.04391273765254199\ \(0\)\
\-\ tuberculum\\:\\ 0\\.04390470942381921\ \(0\)\
\-\ pseudo\\-aneurysm\\:\\ 0\\.04390470942381921\ \(0\)\
\-\ r\\:\\ 0\\.041957237738765474\ \(0\)\
\-\ appearing\\:\\ 0\\.04106203878001701\ \(0\)\
\-\ scrofula\\:\\ 0\\.04015796790727896\ \(0\)\
\-\ kimura\\:\\ 0\\.04015796790727896\ \(0\)\
\-\ a\\-v\\:\\ 0\\.04015796790727896\ \(0\)\
\-\ infectious\\:\\ 0\\.03971734991852798\ \(0\)\
\-\ chains\\:\\ 0\\.0379662646202078\ \(0\)\
\-\ lymphadenitis\\:\\ 0\\.03577456133313664\ \(0\)\
\-\ mycobacterium\\:\\ 0\\.03520504503228353\ \(0\)\
\-\ expands\\:\\ 0\\.03378685981894574\ \(0\)\
\-\ castleman\\:\\ 0\\.03378685981894574\ \(0\)\
\-\ cervical\\:\\ 0\\.033568555746936526\ \(0\)\
\-\ status\\:\\ 0\\.032976511580342205\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.0320278198165964\ \(0\)\
\-\ parotid\\:\\ 0\\.03145830351574328\ \(0\)\
\-\ fna\\:\\ 0\\.031194572898611217\ \(0\)\
\-\ check\\:\\ 0\\.030943113354638823\ \(0\)\
\-\ displacing\\:\\ 0\\.030702833556958645\ \(0\)\
\-\ expect\\:\\ 0\\.030702833556958645\ \(0\)\
\-\ immune\\:\\ 0\\.030702833556958645\ \(0\)\
\-\ branchial\\:\\ 0\\.03047278158712731\ \(0\)\
\-\ ppd\\:\\ 0\\.03004011830240549\ \(0\)\
\-\ usually\\:\\ 0\\.02805327842018118\ \(0\)\
\-\ others\\:\\ 0\\.02719637183809858\ \(0\)\
\-\ neck\\:\\ 0\\.027126952832632244\ \(0\)\
\-\ m\\.\\:\\ 0\\.02707489694160097\ \(0\)\
\-\ infection\\:\\ 0\\.02685423323321954\ \(0\)\
\-\ febrile\\:\\ 0\\.026614584464085794\ \(0\)\
\-\ mets\\:\\ 0\\.026614584464085794\ \(0\)\
\-\ question\\:\\ 0\\.02650538064074785\ \(0\)\
\-\ therapeutic\\:\\ 0\\.02599019047964339\ \(0\)\
\-\ mass\\:\\ 0\\.025696454204271666\ \(0\)\
\-\ hiv\\:\\ 0\\.025610708000328535\ \(0\)\
\-\ necrotic\\:\\ 0\\.025256128094999816\ \(0\)\
\-\ if\\:\\ 0\\.025067496581412278\ \(0\)\
\-\ h\\/o\\:\\ 0\\.02410167349879409\ \(0\)\
\-\ suspicion\\:\\ 0\\.023964820482662793\ \(0\)\
\-\ sarcoid\\:\\ 0\\.023701089865530725\ \(0\)\
\-\ neoplastic\\:\\ 0\\.023637119824195578\ \(0\)\
\-\ standard\\:\\ 0\\.023637119824195578\ \(0\)\
\-\ diseases\\:\\ 0\\.023268426580808913\ \(0\)\
\-\ fistula\\:\\ 0\\.022651597895579606\ \(0\)\
\-\ cleft\\:\\ 0\\.022546635269325006\ \(0\)\
\-\ fungal\\:\\ 0\\.02239291670002482\ \(0\)\
\-\ tb\\:\\ 0\\.022243448963103145\ \(0\)\
\-\ followup\\:\\ 0\\.02205037824633515\ \(0\)\
\-\ afebrile\\:\\ 0\\.021340453910869816\ \(0\)\
\-\ posterior\\:\\ 0\\.02129338971570215\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.021217131328349972\ \(0\)\
\-\ nodes\\:\\ 0\\.02086319657494723\ \(0\)\
\-\ generally\\:\\ 0\\.020787595266975663\ \(0\)\
\-\ \\'s\\:\\ 0\\.020368071549914\ \(0\)\
\-\ large\\:\\ 0\\.02020045872249816\ \(0\)\
\-\ atypical\\:\\ 0\\.02001908451681057\ \(0\)\
\-\ good\\:\\ 0\\.019764665539199835\ \(0\)\
\-\ \\(\\:\\ 0\\.019523289898482718\ \(0\)\
\-\ \\)\\:\\ 0\\.019284802489548787\ \(0\)\
\-\ recommended\\:\\ 0\\.019148750623798658\ \(0\)\
\-\ especially\\:\\ 0\\.01901189760766736\ \(0\)\
\-\ many\\:\\ 0\\.018984937923823907\ \(0\)\
\-\ tender\\:\\ 0\\.018748166990535296\ \(0\)\
\-\ placement\\:\\ 0\\.018748166990535296\ \(0\)\
\-\ includes\\:\\ 0\\.018620975112642355\ \(0\)\
\-\ reports\\:\\ 0\\.018620975112642355\ \(0\)\
\-\ cysts\\:\\ 0\\.018094369096385766\ \(0\)\
\-\ malignancy\\:\\ 0\\.017849133393521708\ \(0\)\
\-\ process\\:\\ 0\\.017784137755863322\ \(0\)\
\-\ structures\\:\\ 0\\.017784137755863322\ \(0\)\
\-\ 30\\:\\ 0\\.017762645061919324\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.01698483868537841\ \(0\)\
\-\ congenital\\:\\ 0\\.01689275118725642\ \(0\)\
\-\ including\\:\\ 0\\.01667793859996175\ \(0\)\
\-\ would\\:\\ 0\\.01643765880228157\ \(0\)\
\-\ palpable\\:\\ 0\\.016370924554593463\ \(0\)\
\-\ location\\:\\ 0\\.01611193344272375\ \(0\)\
\-\ benign\\:\\ 0\\.01594081279477406\ \(0\)\
\-\ presentation\\:\\ 0\\.015910273699951797\ \(0\)\
\-\ neoplasm\\:\\ 0\\.015730576086010424\ \(0\)\
\-\ week\\:\\ 0\\.015686569828801233\ \(0\)\
\-\ past\\:\\ 0\\.014676753902413159\ \(0\)\
\-\ differential\\:\\ 0\\.014664647726232053\ \(0\)\
\-\ adjacent\\:\\ 0\\.014604520238563607\ \(0\)\
\-\ any\\:\\ 0\\.01454505423282321\ \(0\)\
\-\ clinical\\:\\ 0\\.014212485405762186\ \(0\)\
\-\ primary\\:\\ 0\\.013683158177814576\ \(0\)\
\-\ lymphoma\\:\\ 0\\.013201073699402627\ \(0\)\
\-\ \\,\\:\\ 0\\.013169678863003171\ \(0\)\
\-\ include\\:\\ 0\\.012957586421785334\ \(0\)\
\-\ y\\/o\\:\\ 0\\.012792589350376436\ \(0\)\
\-\ history\\:\\ 0\\.012759076083319821\ \(0\)\
\-\ these\\:\\ 0\\.012020782118691028\ \(0\)\
\-\ anterior\\:\\ 0\\.011896177425744527\ \(0\)\
\-\ or\\:\\ 0\\.010827272961769812\ \(0\)\
\-\ tumor\\:\\ 0\\.01076882325195033\ \(0\)\
\-\ woman\\:\\ 0\\.010669745662102197\ \(0\)\
\-\ well\\:\\ 0\\.01044908623226298\ \(0\)\
\-\ 2\\:\\ 0\\.0099465107919489\ \(0\)\
\-\ \\-\\:\\ 0\\.0099012349119371\ \(0\)\
\-\ multiple\\:\\ 0\\.009728681099887941\ \(0\)\
\-\ treatment\\:\\ 0\\.009349280862707497\ \(0\)\
\-\ is\\:\\ 0\\.009118228838671227\ \(0\)\
\-\ in\\:\\ 0\\.009111291462491998\ \(0\)\
\-\ for\\:\\ 0\\.00788225025559692\ \(0\)\
\-\ to\\:\\ 0\\.00692542878556194\ \(0\)\
\-\ not\\:\\ 0\\.006674695522929381\ \(0\)\
\-\ no\\:\\ 0\\.0046510494632637945\ \(0\)\
\-\ and\\:\\ 0\\.0029190649578197587\ \(0\)\
\-\ of\\:\\ 0\\.0025190010983348853\ \(0\)\
\-\ the\\:\\ 0\\.002241880292491229\ \(0\)\
\-\ \\.\\:\\ 0\\.0021107832274097787\ \(0\)\
\-\ with\\:\\ 0\\.0012649100117825918\ \(0\)\
